ChromaDex (United States)
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for ChromaDex (United States), United States, covering academic research published from 2003 to 2024. Read More.
Open Access Percentage
59%
Total
Publications
68
Total Open
Publications
40
Total
Citations
2.7K
Open Access
Percentage
59%
Total
Publications
68
Total Open
Publications
40
Total
Citations
2.7K
Breakdown
Publisher Open
28%
Both
27%
Other Platform Open
4%
Closed
41%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 27%
10
Hybrid 41%
15
No Guarantees 32%
12
Other Platform Open
Domain 81%
17
Institution 29%
6
Other Internet 14%
3
Preprint 5%
1
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 17 |
Europe PMC | Domain | 6 |
University College London - UCL Discovery | Institution | 2 |
Monash University - Monash University Research Portal | Institution | 2 |
ZB MED - Informationszentrum Lebenswissenschaften - PUBLISSO-Fachrepositorium Lebenswissenschaften | Other Internet | 1 |
University of Oslo - Duo Research Archive | Institution | 1 |
University of Florence - Florence Research | Institution | 1 |
University of California - eScholarship University of California | Institution | 1 |
Universitat de Barcelona - Dipòsit Digital de la Universitat de Barcelona | Institution | 1 |
Queen's University Belfast - Research Portal | Institution | 1 |